Drug
Icodextrin Peritoneal Dialysis Solution
Icodextrin Peritoneal Dialysis Solution is a pharmaceutical drug with 3 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
1(33%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_4
2
67%
Phase Distribution
0
Early Stage
0
Mid Stage
2
Late Stage
Phase Distribution2 total trials
Phase 4Post-market surveillance
2(100.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
1 of 1 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
3
all time
Status Distribution
Active(1)
Completed(1)
Other(1)
Detailed Status
Completed1
Recruiting1
unknown1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
1
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 42 (100.0%)
Trials by Status
completed133%
recruiting133%
unknown133%
Recent Activity
1 active trials
Showing 3 of 3
completed
Observational Study of the Use of Extraneal in Peritoneal Dialysis in Patients
NCT06492031
recruitingphase_4
Icodextrin Postpones the Shift of Low Dose to Full Dose Dialysis in the First Year of Incremental Peritoneal Dialysis
NCT05721404
unknownphase_4
The Difference Between Daily and Alternative Day Use of Icodextrin
NCT05943470
Clinical Trials (3)
Showing 3 of 3 trials
NCT06492031
Observational Study of the Use of Extraneal in Peritoneal Dialysis in Patients
NCT05721404Phase 4
Icodextrin Postpones the Shift of Low Dose to Full Dose Dialysis in the First Year of Incremental Peritoneal Dialysis
NCT05943470Phase 4
The Difference Between Daily and Alternative Day Use of Icodextrin
All 3 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 3